Skip to main navigation Skip to search Skip to main content

Interleukin 17 signaling drives Type I Interferon induced proliferative crescentic glomerulonephritis in lupus-prone mice

  • University of Pittsburgh

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Crescentic glomerulonephritis (cGN) is a severe clinical manifestation in a subset of patients with Systemic lupus erythematosus. Lack of understanding of the pathogenesis of cGN act as a major constraint in treating these patients. Emerging evidence suggest a critical role of IL-17 in the pathogenesis of membranoproliferative glomerulonephritis in lupus. However, the role of IL-17 receptor (IL-17RA) signaling in cGN is unknown. Here, we developed a model of poly I:C-induced Type I Interferon (IFN-I)-dependent cGN in B6.MRL-Faslpr/J (B6.lpr) mice. B6.lpr mice deficient in IL-17RA were protected from IFN-I-dependent cGN. While systemic response was unabated, renal infiltration of alternatively activated macrophages was severely impaired in IL-17RA-/- mice. Finally, we show that IL-17 differentially regulates the expression of macrophage chemo-attractant genes in renal tubular epithelial cells and macrophages in association with IFN-I. These results suggest that neutralization IL-17 may confer better protection in SLE patients with high IFN-I gene signature and cGN.

Original languageEnglish
Pages (from-to)31-36
Number of pages6
JournalClinical Immunology
Volume162
DOIs
StatePublished - Jan 1 2016

Keywords

  • Crescentic glomerulonephritis
  • IL-17
  • Lupus
  • Systemic lupus erythematosus
  • Type I Interferon

Fingerprint

Dive into the research topics of 'Interleukin 17 signaling drives Type I Interferon induced proliferative crescentic glomerulonephritis in lupus-prone mice'. Together they form a unique fingerprint.

Cite this